These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [A population-based case-control study of broncho-vaxom use during pregnancy]. Kazy Z, Czeizel E. Orv Hetil; 2005 Nov 13; 146(46):2359-61. PubMed ID: 16370248 [Abstract] [Full Text] [Related]
43. Orally administered bacterial lysate Broncho-Vaxom for the treatment of common variable immunodeficiency. Litzman J, Lokaj J, Gerylovova A. Allerg Immunol (Paris); 1996 Mar 13; 28(3):81-5. PubMed ID: 8703313 [Abstract] [Full Text] [Related]
44. Study on clinical effect and immunologic mechanism of infants capillary bronchitis secondary bronchial asthma treated with bacterial lysates Broncho-Vaxom. Han RF, Li HY, Wang JW, Cong XJ. Eur Rev Med Pharmacol Sci; 2016 May 13; 20(10):2151-5. PubMed ID: 27249617 [Abstract] [Full Text] [Related]
46. [Treatment of upper respiratory tract infections with broncho-vaxom++: a therapeutic alternative to chemotherapy?]. Tarchalska-Kryńska B, Zawisza E, Rewerski W. Otolaryngol Pol; 1994 May 13; 48(5):435-40. PubMed ID: 7808749 [Abstract] [Full Text] [Related]
47. [Inter-society consensus for the management of respiratory infections: acute bronchitis and chronic obstructive pulmonary disease]. Lopardo G, Pensotti C, Scapellato P, Caberlotto O, Calmaggi A, Clara L, Klein M, Levy Hara G, López Furst MJ, Mykietiuk A, Pryluka D, Rial MJ, Vujacich C, Yahni D. Medicina (B Aires); 2013 May 13; 73(2):163-73. PubMed ID: 23570768 [Abstract] [Full Text] [Related]
48. The cost-effectiveness of OM-85 in managing respiratory tract infections in China. Xuan J, Wang L, Yin H, Xuan D, Zhou Y, Hu S. J Med Econ; 2015 Mar 13; 18(3):167-72. PubMed ID: 25275426 [Abstract] [Full Text] [Related]
50. Salivary immunoglobulin A production in chronic bronchitis patients given an orally administered bacterial extract. Spiropoulos K, Lymberopoulos D, Garantziotis G, Gogos C. Respiration; 1993 Mar 13; 60(6):313-8. PubMed ID: 8290795 [Abstract] [Full Text] [Related]
51. [Clinical study of decoction of invigorating Qi and clearing lung combined standardized myrtol on acute exacerbation of chronic obstructive pulmonary disease (AECOPD)]. Hua ZQ, Chang YJ. Zhongguo Zhong Yao Za Zhi; 2013 Feb 13; 38(3):440-2. PubMed ID: 23668026 [Abstract] [Full Text] [Related]
52. [The effect of Broncho-Vaxom on the IgE and IgG serum levels in patients with bronchial asthma and chronic obstructive lung disease]. Ruef C. Schweiz Med Wochenschr; 1988 Apr 09; 118(14):525-8. PubMed ID: 3375790 [No Abstract] [Full Text] [Related]
53. [Broncho-Vax and IRS 19 in the treatment of recurrent respiratory tract inflammation in children]. Bánovcin P, Minarik M, Rosslerová V, Miklerová M, Cáp J, Pullmann R. Cesk Pediatr; 1992 Nov 09; 47(11):666-9. PubMed ID: 1483278 [Abstract] [Full Text] [Related]
54. Local immunity in patients with chronic bronchitis and the effects of a bacterial extract, Broncho-Vaxom, on T lymphocytes, macrophages, gamma-interferon and secretory immunoglobulin A in bronchoalveolar lavage fluid and other variables. Emmerich B, Emslander HP, Pachmann K, Hallek M, Milatovic D, Busch R. Respiration; 1990 Nov 09; 57(2):90-9. PubMed ID: 2122507 [Abstract] [Full Text] [Related]
57. Clinical and Immunological Benefits of OM-85 Bacterial Lysate in Patients with Allergic Rhinitis, Asthma, and COPD and Recurrent Respiratory Infections. Koatz AM, Coe NA, Cicerán A, Alter AJ. Lung; 2016 Aug 09; 194(4):687-97. PubMed ID: 27117798 [Abstract] [Full Text] [Related]
58. [Immunotherapy with Broncho-Vaxom in the treatment and prevention of recurrent inflammations of the respiratory system]. Král B, Tichý M, Fixa B, Eliás J, Ilnerová A. Cas Lek Cesk; 1984 Sep 28; 123(38-39):1201-4. PubMed ID: 6548664 [No Abstract] [Full Text] [Related]